2018
Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)
PKU GOLIKE® comes to fruition in Italy
La farmaceutica ticinese a Madrid per la CPhI 2018
Paolo Magri nominated as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)
Consegnato il premio di miglior sportivo ticinese dell’anno 2018
Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU management. PKU GOLIKE® by APR can play a role
Helsinn Group supports Satellite Symposium at 14th EADO Congress 2018
Farma Industria Ticino e le imprese farmaceutiche ticinesi a Madrid per la fiera CPhI Worldwide 2018
Cigalah Medpharm announces the launch in Saudi Arabia and United Arab Emirates of Nexodyn® AOS, the Tehclo-based wound cleanser developed by the Swiss Pharma Company APR
Progetto Talenti
Cultura e salute
Linkedin